A Study to Assess the Safety & Tolerability of E2511 in Healthy

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05001152` - Taste Assessment of Ozanimod	Phase 1
Completed	`NCT05029518` - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability	Phase 1
Completed	`NCT04493255` - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants	Phase 1
Completed	`NCT03457649` - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers	Phase 1
Completed	`NCT00995891` - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed	`NCT05043766` - Evaluation of Oral PF614 Relative to OxyContin	Phase 1
Completed	`NCT04466748` - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects	Phase 1
Completed	`NCT00746733` - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC	Phase 1
Completed	`NCT05045716` - A Study of Subcutaneous Lecanemab in Healthy Participants	Phase 1
Active, not recruiting	`NCT02747927` - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children	Phase 3
Completed	`NCT05533801` - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants	Phase 1
Not yet recruiting	`NCT03931369` - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)	Phase 2
Completed	`NCT03279146` - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects	Phase 1
Recruiting	`NCT05619874` - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity	N/A
Active, not recruiting	`NCT05553418` - Investigational On-body Injector Clinical Study	N/A
Completed	`NCT04092712` - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers	Phase 1
Completed	`NCT03983161` - A Pharmacokinetics and Tolerability Study of Fedratinib in Subjects With Moderate and Severe Hepatic Impairment	Phase 1
Active, not recruiting	`NCT05026008` - A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SR1375	Phase 1
Completed	`NCT04625855` - Study of the Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) Following a Single Oral Dose in Healthy Male Subjects	Phase 1
Completed	`NCT04569994` - A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes	Phase 1

NCT number	NCT04547361
Study type	Interventional
Source	Eisai Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	September 14, 2020
Completion date	May 26, 2021

A Study to Assess the Safety and Tolerability of E2511 in Healthy Participants

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms